Key result
Ivabradine is an effective heart-rate reducing agent for symptomatic chronic heart failure, with this review detailing its benefits, indications, pharmacokinetics, and patient management guidelines.
This review outlines the clinical use, benefits, and management of ivabradine as an add-on therapy for symptomatic chronic heart failure.
Answers are grounded in this paper and cite their sources.
Supports ivabradine use in symptomatic HF; leaves open need for updated RCTs in diverse populations.
This article outlines the use of ivabradine as a pharmacological approach in chronic heart failure. Ivabradine is a specific heart-rate reducing agent that is proven to be effective in symptomatic heart failure. This article looks at the benefits of adding ivabradine to standard heart failure therapy, as well as its indications, contraindications and side effects, and explains the underlying pathophysiology and pharmacokinetics. It also provides guidance on safe management and monitoring of patients on ivabradine by explaining the responsibilities of the nurse prescriber or prescribing physician. Information needed for patient counselling is also covered in this article.
No takes yet. Share an insight, caveat, or question.
Deepa Sasidharan (2016) conducted a review in chronic heart failure. Ivabradine was evaluated. Ivabradine is an effective heart-rate reducing agent for symptomatic chronic heart failure, with this review detailing its benefits, indications, pharmacokinetics, and patient management guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: